Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D AMSTERDAM

Showing results (211-220 of 265) with videos related to

Pageof 27
Sort By:
Journal of Affective Disorders|July 6, 2015
Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective studyJay D Amsterdam, Lorenzo Lorenzo-Luaces, Irene Soeller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 5, 2008
Antidepressant medications v. cognitive therapy in people with depression with or without personality disorderJay C Fournier, Robert J DeRubeis, Richard C Shelton, et al.
Pharmacopsychiatry|July 1, 1989
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depressionJ D Amsterdam, D L Dunner, L F Fabre, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 20, 2016
Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rateJay D Amsterdam, Lorenzo Lorenzo-Luaces, Irene Soeller, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depressionMartin P Szuba, Jay D Amsterdam, Antonio T Fernando, et al.
The American Journal of Psychiatry|September 1, 1994
Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled studyM Fava, J F Rosenbaum, P J McGrath, et al.
Behaviour Research and Therapy|May 7, 2013
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapyJay C Fournier, Robert J DeRubeis, Steven D Hollon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary studyAndrew B Newberg, Jay D Amsterdam, Nancy Wintering, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 4, 2016
Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trialJun J Mao, Sharon X Xie, John R Keefe, et al.
Journal of Consulting and Clinical Psychology|April 13, 2011
Two aspects of the therapeutic alliance: differential relations with depressive symptom changeChristian A Webb, Robert J DeRubeis, Jay D Amsterdam, et al.
Pageof 27

Showing results (211-220 of 265) with videos related to

Sort By:
Pageof 27
Journal of Affective Disorders|July 6, 2015
Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective studyJay D Amsterdam, Lorenzo Lorenzo-Luaces, Irene Soeller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 5, 2008
Antidepressant medications v. cognitive therapy in people with depression with or without personality disorderJay C Fournier, Robert J DeRubeis, Richard C Shelton, et al.
Pharmacopsychiatry|July 1, 1989
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depressionJ D Amsterdam, D L Dunner, L F Fabre, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 20, 2016
Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rateJay D Amsterdam, Lorenzo Lorenzo-Luaces, Irene Soeller, et al.
Journal of Clinical Psychopharmacology|July 14, 2005
Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depressionMartin P Szuba, Jay D Amsterdam, Antonio T Fernando, et al.
The American Journal of Psychiatry|September 1, 1994
Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled studyM Fava, J F Rosenbaum, P J McGrath, et al.
Behaviour Research and Therapy|May 7, 2013
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapyJay C Fournier, Robert J DeRubeis, Steven D Hollon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary studyAndrew B Newberg, Jay D Amsterdam, Nancy Wintering, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 4, 2016
Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trialJun J Mao, Sharon X Xie, John R Keefe, et al.
Journal of Consulting and Clinical Psychology|April 13, 2011
Two aspects of the therapeutic alliance: differential relations with depressive symptom changeChristian A Webb, Robert J DeRubeis, Jay D Amsterdam, et al.
Pageof 27